Plexus Corp. (NASDAQ:PLXS) CEO Todd P. Kelsey Sells 4,000 Shares of Stock

Plexus Corp. (NASDAQ:PLXS) CEO Todd P. Kelsey sold 4,000 shares of Plexus stock in a transaction on Wednesday, November 6th. The stock was sold at an average price of $164.83, for a total transaction of $659,320.00. Following the completion of the transaction, the chief executive officer now directly owns 77,026 shares in the company, valued at approximately $12,696,195.58. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Plexus Price Performance

Shares of NASDAQ PLXS opened at $166.77 on Thursday. Plexus Corp. has a twelve month low of $90.18 and a twelve month high of $169.41. The company has a 50 day moving average of $134.51 and a 200 day moving average of $119.30. The company has a quick ratio of 0.71, a current ratio of 1.51 and a debt-to-equity ratio of 0.07. The firm has a market cap of $4.54 billion, a P/E ratio of 41.59 and a beta of 0.87.

Plexus (NASDAQ:PLXS) last announced its earnings results on Wednesday, October 23rd. The technology company reported $1.85 earnings per share for the quarter, beating analysts’ consensus estimates of $1.55 by $0.30. The business had revenue of $1.05 billion during the quarter, compared to analyst estimates of $1.01 billion. Plexus had a net margin of 2.82% and a return on equity of 9.51%. The company’s quarterly revenue was up 2.6% compared to the same quarter last year. During the same period in the previous year, the business earned $1.44 EPS. As a group, research analysts expect that Plexus Corp. will post 6.2 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of the business. Quest Partners LLC grew its stake in shares of Plexus by 36,700.0% during the 2nd quarter. Quest Partners LLC now owns 368 shares of the technology company’s stock valued at $38,000 after acquiring an additional 367 shares during the period. Innealta Capital LLC purchased a new position in shares of Plexus in the second quarter valued at about $51,000. Farther Finance Advisors LLC grew its position in shares of Plexus by 89.4% during the third quarter. Farther Finance Advisors LLC now owns 464 shares of the technology company’s stock worth $63,000 after purchasing an additional 219 shares in the last quarter. EntryPoint Capital LLC raised its stake in Plexus by 56.2% during the 1st quarter. EntryPoint Capital LLC now owns 976 shares of the technology company’s stock valued at $93,000 after purchasing an additional 351 shares during the period. Finally, GAMMA Investing LLC boosted its stake in Plexus by 190.1% in the 3rd quarter. GAMMA Investing LLC now owns 760 shares of the technology company’s stock worth $104,000 after purchasing an additional 498 shares during the period. Hedge funds and other institutional investors own 94.45% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on the company. Benchmark increased their price objective on Plexus from $150.00 to $165.00 and gave the stock a “buy” rating in a report on Monday, October 28th. KeyCorp assumed coverage on Plexus in a report on Tuesday, October 22nd. They issued a “sector weight” rating for the company. Needham & Company LLC lifted their price target on shares of Plexus from $144.00 to $162.00 and gave the company a “buy” rating in a research report on Friday, October 25th. Finally, StockNews.com cut Plexus from a “buy” rating to a “hold” rating in a research report on Wednesday. Four investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $133.50.

About Plexus

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.